Furthermore, in this patient, an augment of CA19-9, and CEA concentration was observed through the progression of the case, suggesting that using these markers together enhances diagnostic accuracy for CRC, and probably related metastasis due to both markers often correlated with more aggressive disease characteristics such as lymph node involvement and metastasis (10, 11). The gene discussed is CEACAM5; the disease is colorectal carcinoma.